Continuus Pharmaceuticals, Inc. — Form D
Continuus Pharmaceuticals, Inc. of Woburn, MA, a company, filed a Form D exempt-offering notice with the SEC on 2019-09-11. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-09-11
- Form: D
- Accession: 0001577501-19-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 20
- Date of first sale: 2019-08-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-348478
Issuer
- Name: Continuus Pharmaceuticals, Inc.
- CIK: 0001577501
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 25-R Olympia Avenue, Woburn, MA, 01801
- Phone: (781) 281-0226
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Mark Bamforth | Director | Glasgow, X0 |
| Jonathan Fleming | Director | Cambridge, MA |
| Salvatore Mascia | Director | Woburn, MA |
| Andrea Semprini | Director | Woburn, MA |
| Bayan Takizawa | Director | Woburn, MA |
| Bernhardt Trout | Director | Woburn, MA |
| Salvatore Mascia | Executive Officer | Woburn, MA |
| Nicola Maron | Director | Castenaso (Bologna), L6 |
Other filings by this issuer (2)
More